Todd Asset Management LLC Amgen Inc Transaction History

Todd Asset Management LLC

$4.62 Billion
Q2 2024

A detailed history of Todd Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Todd Asset Management LLC holds 125,359 shares of AMGN stock, worth $40.4 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

125,359

Previous 126,010 0.52%

Holding current value

$40.4 Million

Previous $35.8 Million 9.33%

% of portfolio

0.85%

Previous 0.77%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$262.75 - $319.31 $171,050 - $207,870	-651 Reduced 0.52%	125,359 $39.2 Million
Q1 2024 May 15, 2024	SELL	$268.87 - $324.56 $2.73 Million - $3.3 Million	-10,153 Reduced 7.46%	126,010 $35.8 Million
Q4 2023 Feb 06, 2024	SELL	$255.7 - $288.46 $321,926 - $363,171	-1,259 Reduced 0.92%	136,163 $39.2 Million
Q3 2023 Nov 02, 2023	BUY	$218.65 - $271.46 $92,707 - $115,099	424 Added 0.31%	137,422 $36.9 Million
Q2 2023 Aug 01, 2023	SELL	$214.27 - $253.37 $102,849 - $121,617	-480 Reduced 0.35%	136,998 $30.4 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $29,578 - $36,051	131 Added 0.1%	137,478 $33.2 Million
Q4 2022 Feb 02, 2023	SELL	$229.03 - $291.01 $88,634 - $112,620	-387 Reduced 0.28%	137,347 $36.1 Million
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $325,467 - $367,067	-1,450 Reduced 1.04%	137,734 $31 Million
Q2 2022 Jul 29, 2022	BUY	$230.71 - $256.74 $782,106 - $870,348	3,390 Added 2.5%	139,184 $33.9 Million
Q1 2022 Apr 27, 2022	SELL	$219.27 - $242.57 $245,801 - $271,920	-1,121 Reduced 0.82%	135,794 $32.8 Million
Q4 2021 Feb 03, 2022	SELL	$198.88 - $227.6 $1.37 Million - $1.57 Million	-6,911 Reduced 4.81%	136,915 $30.8 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $188,920 - $221,343	-890 Reduced 0.61%	143,826 $30.6 Million
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $48,818 - $54,160	-209 Reduced 0.14%	144,716 $35.3 Million
Q1 2021 May 06, 2021	SELL	$221.91 - $258.6 $101,190 - $117,921	-456 Reduced 0.31%	144,925 $36.1 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $4.67 Million - $5.57 Million	-21,603 Reduced 12.94%	145,381 $33.4 Million
Q3 2020 Nov 06, 2020	BUY	$234.65 - $260.95 $101,134 - $112,469	431 Added 0.26%	166,984 $42.4 Million
Q2 2020 Aug 06, 2020	SELL	$197.81 - $242.74 $2.58 Million - $3.17 Million	-13,059 Reduced 7.27%	166,553 $39.3 Million
Q1 2020 May 07, 2020	SELL	$182.24 - $241.7 $4.28 Million - $5.67 Million	-23,474 Reduced 11.56%	179,612 $36.4 Million
Q4 2019 Jan 30, 2020	SELL	$189.21 - $243.2 $16.1 Million - $20.7 Million	-85,166 Reduced 29.55%	203,086 $49 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $19.4 Million - $23.2 Million	111,423 Added 63.01%	288,252 $55.8 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $132,859 - $155,741	-797 Reduced 0.45%	176,829 $32.6 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $94,956 - $107,037	-525 Reduced 0.29%	177,626 $33.7 Million
Q4 2018 Feb 12, 2019	BUY	$178.4 - $208.25 $1.85 Million - $2.16 Million	10,366 Added 6.18%	178,151 $34.7 Million
Q3 2018 Nov 09, 2018	SELL	$185.29 - $208.89 $462,298 - $521,180	-2,495 Reduced 1.47%	167,785 $34.8 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $108,264 - $121,604	-652 Reduced 0.38%	170,280 $31.4 Million
Q1 2018 May 10, 2018	SELL	$169.43 - $198.0 $1.98 Million - $2.31 Million	-11,683 Reduced 6.4%	170,932 $29.1 Million
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $1.22 Million - $1.36 Million	-7,230 Reduced 3.81%	182,615 $31.8 Million
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $4.14 Million - $4.72 Million	24,720 Added 14.97%	189,845 $35.4 Million
Q2 2017 Aug 09, 2017	BUY	N/A	165,125	165,125 $28.4 Million

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $173B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Todd Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Todd Asset Management LLC with notifications on news.

Account

Todd Asset Management LLC Amgen Inc Transaction History